Healthcare provider profile · identity verified

Nabil Suliman, MD

Internal Medicine · LIVONIA, MI · NPI 1952377160

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	799	242
Metformin Hcl	Metformin Hcl	509	157
Lisinopril	Lisinopril	422	134
Amlodipine Besylate	Amlodipine Besylate	388	130
Levothyroxine Sodium	Levothyroxine Sodium	363	98
Losartan Potassium	Losartan Potassium	294	87
Omeprazole	Omeprazole	290	104
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	276	113
Tamsulosin Hcl	Tamsulosin Hcl	265	84
Simvastatin	Simvastatin	230	72
Diclofenac Sodium	Diclofenac Sodium	226	90
Linzess	Linaclotide	204	69
Meloxicam	Meloxicam	196	73
Metoprolol Succinate	Metoprolol Succinate	195	65
Famotidine	Famotidine	189	77
Fluticasone Propionate	Fluticasone Propionate	182	70
Jardiance	Empagliflozin	177	48
Albuterol Sulfate Hfa	Albuterol Sulfate	175	75
Januvia	Sitagliptin Phosphate	170	38
Glimepiride	Glimepiride	155	43
Ibuprofen	Ibuprofen	150	67
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	146	65
Metoprolol Tartrate	Metoprolol Tartrate	142	39
Gabapentin	Gabapentin	140	61
Azithromycin	Azithromycin	133	119
Hydrochlorothiazide	Hydrochlorothiazide	131	45
Alcohol Prep Pads	Alcohol Antiseptic Pads	129	36
Azelastine Hcl	Azelastine Hcl	124	67
Eliquis	Apixaban	121	24
Prednisone	Prednisone	117	88
Pantoprazole Sodium	Pantoprazole Sodium	108	41
Tradjenta	Linagliptin	108	18
Escitalopram Oxalate	Escitalopram Oxalate	104	37
Furosemide	Furosemide	101	41
Rosuvastatin Calcium	Rosuvastatin Calcium	100	36
Esomeprazole Magnesium	Esomeprazole Magnesium	98	27
Montelukast Sodium	Montelukast Sodium	98	29
Clopidogrel	Clopidogrel Bisulfate	91	35
Carvedilol	Carvedilol	90	26
Finasteride	Finasteride	88	26
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	86	31
Comfort Ez Pen Needle	Pen Needle, Diabetic	82	17
Myrbetriq	Mirabegron	79	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	76	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	74	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	74	26
Trulicity	Dulaglutide	74	20
Naproxen	Naproxen	71	29
Ammonium Lactate	Ammonium Lactate	70	28
Metformin Hcl Er	Metformin Hcl	68	22
Ventolin Hfa	Albuterol Sulfate	65	31
Farxiga	Dapagliflozin Propanediol	60	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	22
Alendronate Sodium	Alendronate Sodium	59	18
Tramadol Hcl	Tramadol Hcl	59	27
Sertraline Hcl	Sertraline Hcl	58	18
Levofloxacin	Levofloxacin	56	44
Pregabalin	Pregabalin	56	17
Janumet	Sitagliptin Phos/Metformin Hcl	53	11
Duloxetine Hcl	Duloxetine Hcl	52	21
Meclizine Hcl	Meclizine Hcl	49	25
Sumatriptan Succinate	Sumatriptan Succinate	49	suppressed
Potassium Chloride	Potassium Chloride	48	18
Triamcinolone Acetonide	Triamcinolone Acetonide	48	29
Hydralazine Hcl	Hydralazine Hcl	47	19
Ketoconazole	Ketoconazole	46	16
Xarelto	Rivaroxaban	46	suppressed
Fenofibrate	Fenofibrate	45	suppressed
Methocarbamol	Methocarbamol	45	25
Ozempic	Semaglutide	43	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	41	17
Lidocaine	Lidocaine	41	22
Pioglitazone Hcl	Pioglitazone Hcl	41	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	41	19
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	35
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	39	26
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	39	13
Glipizide	Glipizide	39	suppressed
Cefdinir	Cefdinir	38	35
Mounjaro	Tirzepatide	38	suppressed
Glipizide Er	Glipizide	37	11
Allopurinol	Allopurinol	36	15
Spironolactone	Spironolactone	36	11
Celecoxib	Celecoxib	33	14
Vitamin D2	Ergocalciferol (Vitamin D2)	33	suppressed
Ezetimibe	Ezetimibe	32	15
Warfarin Sodium	Warfarin Sodium	31	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Trazodone Hcl	Trazodone Hcl	29	13
Dexlansoprazole Dr	Dexlansoprazole	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	15
Memantine Hcl Er	Memantine Hcl	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	23	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Atenolol	Atenolol	22	suppressed
Brilinta	Ticagrelor	21	suppressed
Bumetanide	Bumetanide	21	suppressed
Dutasteride	Dutasteride	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	11
Promethazine Hcl	Promethazine Hcl	21	13
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	20	suppressed
Fenofibrate	Fenofibrate,micronized	20	suppressed
Mupirocin	Mupirocin	20	17
Terazosin Hcl	Terazosin Hcl	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Ibu	Ibuprofen	19	11
Megestrol Acetate	Megestrol Acetate	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Valsartan	Valsartan	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Hydrocortisone	Hydrocortisone	18	11
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Novolog Flexpen	Insulin Aspart	18	suppressed
Temazepam	Temazepam	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Fluconazole	Fluconazole	17	12
Lansoprazole	Lansoprazole	17	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	17	suppressed
Desloratadine	Desloratadine	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Cephalexin	Cephalexin	14	13
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	14	11
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Mirabegron Er	Mirabegron	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Risperidone	Risperidone	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Febuxostat	Febuxostat	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	suppressed
Anastrozole	Anastrozole	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Nexium	Esomeprazole Magnesium	12	suppressed
Torsemide	Torsemide	12	suppressed
Baclofen	Baclofen	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Procto-Med Hc	Hydrocortisone	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error